Skip to main content

Table 2 Short-term outcomes (n = 144)

From: Lateral lymph node dissection for mid-to-low rectal cancer: is it safe and effective in a practice-based cohort?

Parameter

ME + LLD (n = 72)

ME (n = 72)

p-value

Approach

0.300

 Open

42 (58.3%)

49 (68.0%)

 

 Laparoscopic

30 (41.7%)

23 (32.0%)

 

Sphincter preserved

37 (51.3%)

39 (54.1%)

0.868

Extent of LLD

 

 LD2

61 (84.7%)

 

 LD1

11 (15.3%)

 

Operated by

  

0.180

 TS

37 (51.3%)

28 (38.8%)

 

 NTS

35 (48.7%)

44 (61.2%)

 

Operative time (min)

349 (110–834)

237 (110–623)

< 0.001

Blood loss (gram)

392 (10–2770)

295 (5–9892)

0.270

Complications (CD ≥ Grade 3)

14 (19.4%)

12 (16.7%)

0.829

 Anastomotic leakage

4 (5.6%)

6 (8.3%)

0.745

 Ileus

4 (5.6%)

3 (4.2%)

1.000

 Abdominal abscess

2 (2.8%)

2 (2.8%)

1.000

 Pulmonary embolism

1 (1.4%)

0 (0.0%)

1.000

 Wound dehiscence

1 (1.4%)

0 (0.0%)

1.000

 Stoma perforation

1 (1.4%)

0 (0.0%)

1.000

 Abdominal abscess

1 (1.4%)

0 (0.0%)

1.000

 Respiratory suppression due to anesthetic overdose

0 (0.0%)

1 (1.4%)

1.000

Mortality

0 (0.0%)

0 (0.0%)

POS (days)

18 (8–114)

22 (8–72)

0.059

R1 resection

7 (9.7%)

8 (11.1%)

1.000

Harvested lymph node

31 (10–109)

16 (2–83)

< 0.001

  1. Continuous variables are presented as medians with ranges. Discrete variables are presented as numbers with percentages
  2. LLD Lateral lymph node dissection, TS Trained surgeon for colorectal surgery, NTS Non-trained surgeon for colorectal surgery, CD Clavien–Dindo classification, POS Postoperative hospital stay
  3. aOther complications include pulmonary embolism (n = 1), wound dehiscence (n = 1)